The ROAM Robotics Ascend Exoskeleton is a wearable device specifically designed to provide support and assistance to people with mobility impairments. This exoskeleton provides adjustable support for the user's hips and knees, allowing walking and standing with greater ease and stability. The device is lightweight and can be adjusted to fit different body types and sizes. With its rechargeable battery, the Ascend exoskeleton can support the user for an extended period of time, making it a promising solution for people who want to improve their mobility...
Everything you need to know about the features and benefits of the Robotics Ascend: Wearable robotic orthosis from ROAM need to know.
Participants with knee osteoarthritis experience an average pain reduction of 46 % with Ascend.
67 % of study participants showed functional improvement with daily activities.
Enjoy daily tasks with independence, such as going to the grocery store or climbing stairs.
Ascend's MSRP is $7000 without insurance (financing options may be available for qualified candidates).
Ascend is designed to support your daily activities and everyday movements such as walking, kneeling, sitting and getting up from a chair as well as going up and down stairs.
Ascend is a smart knee brace designed to relieve knee pain and intuitively support daily mobility. The customized, lightweight and comfortable design reduces stress on the knee and adapts to the user as needed, enabling a confident, active and healthy lifestyle. Intelligent sensor technology assists in performing common movements such as walking, kneeling, standing, sitting and climbing stairs. Ascend provides a safe, non-invasive and non-surgical option for pain relief and mobility limitations associated with osteoarthritis, knee instability and/or weak quadriceps.
Ascend is FDA approved and indicated for people with knee pain due to osteoarthritis, instability and weak quads. If you rely on a wheelchair for all of your activities, Ascend may not be right for you. Please talk to your doctor to determine if Ascend is right for you.
Ascend is indicated for people with knee pain due to osteoarthritis (natural or due to injury), instability, and weak quads. Ascend is not recommended for people with recent injuries. Please talk to your doctor to determine if Ascend is right for you.
The SmartPack weighs approximately 11-12 lbs. The leg weighs approximately 2 - 2.5 lbs.
Ascend is water resistant, but neither waterproof nor designed for use in water. Immersing the orthosis or SmartPack in water or cleaning solution will damage the device.
No, Ascend is a single-leg application. Wearing an Ascend orthosis on both knees does not work. We often find that when there is pain in both knees, one knee is usually worse than the other. Ascend can be used on the leg with more severe pain and can help improve compensation and balance of both legs, improving the overall experience during daily activities.
The Ascend system is designed to be suitable for air travel. Specific instructions for complying with TSA regulations when carrying Ascend on board aircraft are included in the user manual.
No, Ascend doesn't help you get off the ground. Ascend helps you perform common movements such as walking, kneeling, standing, sitting, and going up or down stairs.
Ascend is designed for your daily activities, and the SmartPack is designed to be disconnected when you are in a vehicle. It is not recommended to drive with the Ascend on.
Yes, it depends on your specific situation. We recommend you talk to your doctor to see if Ascend is recommended for you.
No, Ascend is designed to support everyday activities such as walking, climbing stairs, standing up or sitting down on a bench, squatting or kneeling. It is not intended for sports or high intensity activities such as running, tennis, soccer, basketball, etc.
Tim Swift (founder) received his PhD from UC Berkeley, where he developed the technical basis for many of the exoskeletons in commercial use today. He was part of the original team at Ekso Bionics who invented a rigid exoskeleton for paraplegics. ROAM has received a total of $12 million in 2 rounds of funding. The most recent funding was raised in a Series A round on November 29, 2018.
ROAM is funded by 8 investors. Yamaha Motor Ventures & Laboratory Silicon Valley and Menlo Ventures are the most recent investors. ROAM has a post-money valuation in the range of $10 million to $50 million as of November 29, 2018, according to PrivCo. Sign up for a free trial to see the exact valuation and search for companies with similar valuations.
Image sources: All images and graphics are copyrighted and property of ©.
2025
Roam Robotics.